Venetoclax Basket Trial
A Phase I Study of Venetoclax in Combination With Cytotoxic Chemotherapy, Including Calaspargase Pegol, for Children, Adolescents and Young Adults With High-Risk Hematologic Malignancies
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 30 patients (estimated)
- Sponsors
- Dana-Farber Cancer Institute
- Collaborators
- University of Colorado Cancer Center, Boston Children's Hospital, Children's Cancer Research Fund, AbbVie, Servier Pharmaceuticals LLC
- Tags
- BCL-2 Inhibitor, Antimetabolites, Chemotherapy, Hypomethylating Agents (HMA), Steroid
- Trial Type
- Treatment
- Last Update
- SparkCures ID
- 1610
- NCT Identifier
- NCT05292664
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.